1 Introduction
==============

Detecting copy number variants (CNVs) with whole exome sequencing data is challenging because CNV breakpoints are likely to fall outside of the exome. Almost all CNV-calling algorithms for whole exome sequencing base their calls on read depths within the CNV, which are linearly correlated to copy number state. Previously published algorithms include CoNIFER ([@btv547-B4]), XHMM ([@btv547-B2]), ExomeDepth ([@btv547-B5]) and CANOES ([@btv547-B1]).

Depth-of-coverage is subject to both systematic biases (often related to sequence GC-content) and stochastic volatility (which is exacerbated by variation in input DNA quality). CNV callers must normalize coverage data to correct for systematic biases and characterize the expected coverage profile given diploid copy number, so that true CNVs can be distinguished from noise. Variability in sample preparation and sequencing procedures result in additional coverage biases, often referred to as 'batch effects'.

CoNIFER and XHMM use principal components analysis to identify and remove systematic biases, while ExomeDepth and CANOES handle bias by normalizing each sample's coverage against the average in a small, 'custom' reference panel of samples with coverage profiles that are highly correlated to the individual sample in question. Both strategies have quadratic time complexity and large RAM requirements.

Each of these algorithms assumes that reference panel samples are always diploid (presenting a unimodal coverage distribution at each exon), resulting in inaccurate genotypes at common CNV loci. They can also mistake population stratification of common CNVs for batch effects if true batch effects are minimal.

2 Algorithm
===========

The CLAMMS algorithm has three steps, outlined in [Figure 1](#btv547-F1){ref-type="fig"}. Coverage values for individual samples are normalized independently to correct for GC-amplification bias and overall average depth-of-coverage. Low-mappability regions are filtered altogether, as the read depths in these regions do not accurately represent the sequence dosage in the genome.Given a reference panel of samples, a finite mixture model is fit for each exome capture region. Each mixture component models the expected distribution of coverage across samples for a particular integer copy number state. Model parameters will vary from exon to exon, correcting for additional non-GC-related coverage biases. Exome-wide, copy numbers 0--3 are considered; in known duplication regions, copy numbers 4--6 are considered as well (see [Supplement Section S1.3](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv547/-/DC1)).CNVs are called for individual samples using a hidden Markov model (HMM). The input sequence to the HMM is the sample's normalized coverage values for each region. Emission probabilities are based on the trained mixture models and transition probabilities are similar to those used by XHMM. Fig. 1.Overview of the CLAMMS CNV-calling pipeline. A reference panel is selected for each sample based on seven sequencing QC metrics using an efficient *k*-d tree data structure. After selecting reference panels, each sample and its corresponding reference panel may be processed in parallel across processes and/or servers, requiring only ∼50 MB of RAM per process

The details of each step are described in the [Supplementary Material](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv547/-/DC1). Mixture models allow for copy number polymorphic loci to be handled naturally, while the HMM incorporates the prior expectation that nearby anomalous signals are more likely to be part of a single CNV than multiple small CNVs. Mixture models have previously been used by Genome STRiP (a CNV caller for whole-genome data, [@btv547-B3]), and XHMM, ExomeDepth and CANOES use HMMs; but to our knowledge, no previous CNV-calling algorithm has integrated both in a single probabilistic model.

Similar to CANOES and ExomeDepth, we handle data heterogeneity by selecting a 'custom' reference panel for each sample. Our CNV calling pipeline (discussed further in the [Supplementary Material](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv547/-/DC1)) works as follows: We define a distance metric between samples based on seven sequencing quality control metrics from Picard (<http://broadinstitute.github.io/picard>).Each newly sequenced sample is added to a *k*-d tree in this metric space. CNVs are called using a reference panel consisting of the sample's 100 nearest neighbors, which are found efficiently using the *k*-d tree.

Indexing *n* samples and finding the *k* nearest-neighbors for each sample takes O(*kn log n*) time. Once the nearest neighbors have been found, calling CNVs for the *n* samples takes O(*kn*) time, so the complexity of the whole pipeline is O(*kn log n*). This improves on the O(*n*^2^) complexity of previous algorithms, which all compare the coverage profile of each sample to every other sample.

3 Validation
============

We performed computational and biological validations to compare the performance of CLAMMS and previous algorithms. We summarize our results here; details are provided in the [Supplementary Material](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv547/-/DC1).

First, we used CLAMMS, XHMM, CoNIFER, CANOES and ExomeDepth to call CNVs for an eight-member pedigree, sequenced in three technical replicates. Ninety-two additional samples were provided as a reference panel. By definition, most CNVs in the pedigree are common variants. CLAMMS called a mean of 13.5 CNV/sample. Ninety-five percent of its calls in children were inherited and 92% of calls were consistent across all technical replicates. XHMM, CoNIFER and CANOES were insensitive to common variants; ExomeDepth is sensitive, but $< 2/3$ of its calls were inherited.

Second, we compared CNV calls from each algorithm (except CANOES, which ran out of memory on a server with 30 GB RAM) against 'gold-standard' calls from microarrays (PennCNV, [@btv547-B7]) for 3164 samples. We limited this analysis to rare variants (AF $\leq$ 0.1%) to avoid false positives related to batch effects in the array data. Using high-quality array-based rare-variant calls as the ground-truth, CLAMMS had the best performance (*F*-score 6.6% higher than ExomeDepth, 9.3% higher than XHMM and over double that of CoNIFER).

Finally, we used TaqMan quantitative polymerase chain reaction to validate a random subset of CNVs predicted by CLAMMS at 20 rare variant loci and 19 common variant loci that overlap disease-associated genes in the Human Gene Mutation Database (not limited to genes associated with CNVs; 7 430 disease genes in total; [@btv547-B6]); 19/20 (95%) rare variants were validated. At the common variant loci, CLAMMS genotypes achieved mean precision/recall values of 99.0% and 94.0%, respectively. ExomeDepth also had near-perfect performance for mid-frequency CNVs but had inaccurate genotypes at highly polymorphic loci (see [Supplementary Table S5](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv547/-/DC1)).
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